NEWS

INR stories: Jan Gralla's uncensored interview

Re-treatment of a giant paraclinoid aneurysm guided by nOCT imaging

Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based C...

The FDA clearance of enVast redefines coronary thrombectomy treatment and further expands Vesalio’s commercial platform.Plano, Texas – Dec 11, 2025

A new chapter opens, the spirit of LINNC remains

The best of LINNC Asia 2025

Highlights of LINNC Asia - Day 1: complex aneurysms, AVMs and VOGM

CREST-2: Carotid Artery Stenting for Primary Stroke Prevention

Inside SVIN 2025: innovation in neurointervention, real-world evidence, and global impact

Vesalio Receives Two FDA 510(k) Clearances, Advancing Its Comprehensive...

The FDA clearances expand Vesalio’s thrombectomy portfolio to support its growth strategy in the rapidly expanding multi-billion-dollar global thrombectomy market.Plano, Texas – November 18, 2025

INR stories: Adam Arthur's uncensored interview